Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Variations in human ACE2 genetics associated with coronavirus susceptibility

In a recent study, the researchers sought to understand the genetic variability in ACE2 that may contribute to inconsistent clinical outcomes of COVID-19.

25 Jul 2021

Pre-transplant cardio-cerebrovascular diseases impact hematopoietic cell transplant outcomes

Hematopoietic cell transplantation (HCT) is a recognized treatment option for certain blood and bone marrow cancers as well as some autoimmune and hereditary disorders.

23 Jul 2021

Women at higher risk of post-COVID-19 syndrome

To better understand post-COVID sequelae, researchers at the University Hospital Basel and the University Hospital Zurich conducted a multicentre prospective observational cohort study.

8 Jul 2021

AI tool measures fat around the heart to predict a patient's risk of diabetes

A team led by researchers from Queen Mary University of London has developed a new artificial intelligence (AI) tool that is able to automatically measure the amount of fat around the heart from MRI scan images.

7 Jul 2021

Researchers identify specific biomarkers for coronary microvascular disease

Although cardiovascular disease is the main cause of illness among women in the U.S., certain conditions such as coronary microvascular disease (CMD) cannot be easily diagnosed. In a new study, researchers at the University of Illinois Urbana-Champaign have identified specific biomarkers for CMD, which might reduce future hospitalizations.

30 Jun 2021

Cross-sectional study explores differences in biomarkers in fulminant and non-fulminant COVID-19 myocarditis

Researchers from the US recently conducted a study to examine the clinical course and echocardiographic and lab testing across clinically defined fulminant and non-fulminant COVID-19 myocarditis. This study is published on the preprint server, medRxiv.*

11 Jun 2021

AI-powered tool could accelerate the diagnosis of cardiovascular diseases

A team of researchers from Nanyang Technological University, Singapore, Ngee Ann Polytechnic, Singapore, and the National Heart Centre Singapore have invented a tool that could speed up the diagnosis of cardiovascular diseases.

8 Jun 2021

Exercise may be the most effective treatment for depression in coronary heart disease patients

A study by RCSI indicates that exercise is probably the most effective short-term treatment for depression in people with coronary heart disease, when compared to antidepressants and psychotherapy or more complex care.

8 Jun 2021

Ultrasound examinations can be deployed to detect and treat lung congestion in hemodialysis patients

Accumulation of water in the lungs (lungcongestion) is a common condition in hemodialysis patients, particularly in those at high cardiovascular risk, like those presenting coronary artery disease and/or heart failure.

7 Jun 2021

Using AI technology to predict the risk of coronary heart disease

A new project using artificial intelligence technology could spell a medical breakthrough for people suffering from, or at risk of, coronary artery disease, the single leading cause of death in Australia.

4 Jun 2021

Henry Ford Hospital cardiologists are first in the U.S. to implant circulatory support device

Cardiologists at Henry Ford Hospital are first in the U.S. and second in the world to implant a circulatory support device that is being investigated in a clinical trial for patients hospitalized with acute decompensated heart failure (ADHF) and worsening kidney function, a condition known as cardiorenal syndrome.

4 Jun 2021

Expanding genomic research into different ancestries yields more and better results

Today The Lundquist Institute announced that its investigators contributed data from several studies, including data on Hispanics, African-Americans and East Asians, to the international MAGIC collaboration, composed of more than 400 global academics, who conducted a genome-wide association meta-analysis led by the University of Exeter.

31 May 2021

COLCORONA study shows that colchicine can reduce complications in certain COVID-19 patients

The Montreal Heart Institute announces that the COLCORONA study results are published today in The Lancet Respiratory Medicine.

28 May 2021

A study reports the first case of an upper extremity deep vein thrombosis (DVT) recurrence due to COVID-19 infection

Researchers have reported the first case of COVID-19 triggering a rare occurrence of potentially severe blood clots forming in the arms.

19 May 2021

Randomized clinical trials compare effects of coronary revascularization versus medical therapy alone

A rigorous meta-analysis of randomized clinical trials (RCTs) that compared the effects of medical therapies alone with medical therapies plus revascularization in patients with stable ischemic heart disease (SIHD) was presented at EuroPCR on May 18, 2021.

19 May 2021

New approach could allow cardiologists to predict future heart attacks in high-risk patients

Analysing the forces at work behind the obstructions that cause heart attacks is crucial for identifying patients at risk of these events, says a study published today in eLife.

19 May 2021

Researchers link “genetic signatures” of bacteria in the human gut to multiple diseases

We are truly never alone, not even within our own bodies. Human beings play host to trillions of bacteria, fungi, viruses, and other microorganisms that make up the human microbiome.

18 May 2021

Stair-climbing routines provide cardiovascular and muscular benefits to heart patients

A team of McMaster University researchers who studied heart patients found that stair-climbing routines, whether vigorous or moderate, provide significant cardiovascular and muscular benefits.

18 May 2021

Hyperinvasive approach is an effective treatment strategy for out-of-hospital cardiac arrest

A subgroup of patients who experienced an out-of-hospital cardiac arrest (OHCA) that did not respond to standard advanced cardiac life support (ACLS), were immediately transported to a cardiac care center, and placed on a device similar to a heart-lung bypass machine were more likely to have survived with good brain function six months later than similar patients who received standard care at the site where the OHCA occurred.

18 May 2021

Farxiga approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes

Approval is the most significant advancement in the treatment of chronic kidney disease in more than 20 years. In DAPA-CKD Phase III trial, Farxiga demonstrated unprecedented reduction in the risk of the composite of worsening of renal function, end-stage kidney disease and cardiovascular or renal death.

From AstraZeneca 14 May 2021

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Variations in human ACE2 genetics associated with coronavirus susceptibility

Pre-transplant cardio-cerebrovascular diseases impact hematopoietic cell transplant outcomes

Women at higher risk of post-COVID-19 syndrome

AI tool measures fat around the heart to predict a patient's risk of diabetes

Researchers identify specific biomarkers for coronary microvascular disease

Cross-sectional study explores differences in biomarkers in fulminant and non-fulminant COVID-19 myocarditis

AI-powered tool could accelerate the diagnosis of cardiovascular diseases

Exercise may be the most effective treatment for depression in coronary heart disease patients

Ultrasound examinations can be deployed to detect and treat lung congestion in hemodialysis patients

Using AI technology to predict the risk of coronary heart disease

Henry Ford Hospital cardiologists are first in the U.S. to implant circulatory support device

Expanding genomic research into different ancestries yields more and better results

COLCORONA study shows that colchicine can reduce complications in certain COVID-19 patients

A study reports the first case of an upper extremity deep vein thrombosis (DVT) recurrence due to COVID-19 infection

Randomized clinical trials compare effects of coronary revascularization versus medical therapy alone

New approach could allow cardiologists to predict future heart attacks in high-risk patients

Researchers link “genetic signatures” of bacteria in the human gut to multiple diseases

Stair-climbing routines provide cardiovascular and muscular benefits to heart patients

Hyperinvasive approach is an effective treatment strategy for out-of-hospital cardiac arrest

Farxiga approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in